| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/28/2007 | US20070149485 Selected dosage for the treatment of cardiovascular and related pathologies |
| 06/28/2007 | US20070149484 Novel pyridopyrazines and their use as modulators of kinases |
| 06/28/2007 | US20070149483 Methods and compounds for modulating triglyceride and vldl secretion |
| 06/28/2007 | US20070149482 Phosphonium salts and their method of preparation |
| 06/28/2007 | US20070149481 N,n-bridged, nitrogen-substituted carbacyclic indolocarbazoles as protein kinase inhibitors |
| 06/28/2007 | US20070149480 PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| 06/28/2007 | US20070149479 Nanoparticulate inclusion and charge complex for pharmaceutical formulations |
| 06/28/2007 | US20070149478 Compositions of plant carbohydrates as dietary supplements |
| 06/28/2007 | US20070149477 Stimulating a Th2 response by administering multivalent LNFPIII, an immunomodulatory glycan Lacto-N-Fucopentaose III, which contains the Lewis X trisaccharide (CD!%/antigen/); autoimmune disease; antidiabetic agents; antiarthritic agents; multiple sclerosis; colitis; psoriasis |
| 06/28/2007 | US20070149476 Combination Comprising Combretastatin and Anticancer Agents |
| 06/28/2007 | US20070149466 Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
| 06/28/2007 | US20070149465 Compositions and methods for prevention and treatment of cachexia |
| 06/28/2007 | US20070149464 Combination |
| 06/28/2007 | US20070149463 Bifunctional macrolide heterocyclic compounds and methods of making and using the same |
| 06/28/2007 | US20070149462 Nucleotide and oligonucleotide prodrugs |
| 06/28/2007 | US20070149461 Use of canthin-6-one, plant extracts containing same and derivatives thereof in the treatment of trypanosomiases |
| 06/28/2007 | US20070149454 Controlled Release Delivery System for Nasal Applications and Method of Treatment |
| 06/28/2007 | US20070149452 Method of Treating and/or Preventing Cancers and AIDS using Sartans and/or Statins to modulate VDR, and/or PPAR, and/or GCR and/or CB1 receptors; in conjunction with certain bacteriostatic antibiotics |
| 06/28/2007 | US20070149451 For example, vildagliptin and orlistat or phentermine |
| 06/28/2007 | US20070149441 Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
| 06/28/2007 | US20070149440 Transferrin and transferrin-based compositions for diabetes treatment |
| 06/28/2007 | US20070148744 inhibitors of vacuolar-type H+-ATPase; antibiotic; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16- [(1S,2R,3S)-3-[(2R,4R,5S,6R)-2,4-dihydroxy-6- isopropyl-5-methyl-2-tetrahydropyranyl]-2- hydroxy-1-methylbutyl]-8-hydroxy-3,15- dimethoxy-5,7,9,11-tetramethyl-1- oxacyclohexadeca-3,5,11,13-tetraen-2-one |
| 06/28/2007 | US20070148734 Hyaluronic acid mediated adenoviral transduction |
| 06/28/2007 | US20070148711 Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alpha |
| 06/28/2007 | US20070148703 Method of screening remedy for breast cancer |
| 06/28/2007 | US20070148700 Site-specific aminoglycoside derivatives for use in immunodiagnostic assays |
| 06/28/2007 | US20070148689 Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases |
| 06/28/2007 | US20070148643 Treatment of Huntington's Disease with EPA |
| 06/28/2007 | US20070148630 Removal of Adenine During a Pathogen Reduction Process in Whole Blood or Red Blood Cells by Dilution |
| 06/28/2007 | US20070148268 Chemical compounds and their use as therapeutic agent and means of quality assessment of herbal medicines |
| 06/28/2007 | US20070148264 Agent for the prevention and/or treatment of septicemia |
| 06/28/2007 | US20070148263 comprises curcumin and an essential oil of turmeric |
| 06/28/2007 | US20070148262 Bactericidal and virucidal composition containing natural products |
| 06/28/2007 | US20070148261 Cancer treatment method |
| 06/28/2007 | US20070148260 Method for maintaining cerebral hemispheric oxygen saturation during surgery |
| 06/28/2007 | US20070148259 Parenteral nutrition composition containing iron |
| 06/28/2007 | US20070148256 Pharmacologic-functioning water and usage of the same |
| 06/28/2007 | US20070148255 Compositions for delivery of drug combinations |
| 06/28/2007 | US20070148252 Solid stabilized particles comprising ganaxolone, a hydrophilic polymer (cellulose, polyvinyl alcohol), a wetting agent (sodium lauryl sulfate), a complexing agent (benzoic acid, parabens) that stabilizes particle growth after an initial particle growth and endpoint is reached |
| 06/28/2007 | US20070148250 Loading of a camptothecin drug into colloidal nanoparticles |
| 06/28/2007 | US20070148249 Method of preparation of oral solid dosage form with instant release of acting |
| 06/28/2007 | US20070148247 Pharmaceutical composition which reduces or eliminates drug abuse potential |
| 06/28/2007 | US20070148240 Oral formulation containing itraconazole and methods for manufacturing and using the same |
| 06/28/2007 | US20070148237 Sustained-release formulation of zonisamide |
| 06/28/2007 | US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 06/28/2007 | US20070148235 Pharmaceutical composition |
| 06/28/2007 | US20070148234 Modified release formulation of fenofibric acid in a hydroxypropyl methylcellulose matrix; in vitro dissolution is substantially independent of the dissolution media ionic strength |
| 06/28/2007 | US20070148233 Pharmaceutical formulations of fenofibrate having improved bioavailability |
| 06/28/2007 | US20070148232 Stabilized pharmaceutical solid compositions of low-solubility drugs and poloxamers, and stabilizing polymers |
| 06/28/2007 | US20070148230 Medicament-containing particle and a solid preparation containing the particle |
| 06/28/2007 | US20070148229 Tablet with coloured core |
| 06/28/2007 | US20070148228 Bioavailability; absorption; using a fatty acid, or salt thereof, or fatty ester ; sustained release; histone deacetylase inhibitor |
| 06/28/2007 | US20070148225 PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| 06/28/2007 | US20070148224 Skin treatment compositions containing copper-pigment complexes |
| 06/28/2007 | US20070148223 Skin treatment compositions containing copper-pigment complexes |
| 06/28/2007 | US20070148222 Skin treatment compositions containing copper-pigment complexes |
| 06/28/2007 | US20070148221 Method of producing lipid complexed camptothecin-carboxylate |
| 06/28/2007 | US20070148218 Olanzapine containing transdermal drug delivery compositions |
| 06/28/2007 | US20070148217 Percutaneous absorption type cerebral protective agent |
| 06/28/2007 | US20070148216 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic |
| 06/28/2007 | US20070148212 Feed additive composition for ruminants, and feed containing the same, and method of fabricating such feed additive composition for ruminants |
| 06/28/2007 | US20070148210 Composition for Enhancing Physical Performance |
| 06/28/2007 | US20070148209 Allergic constitution ameliorator |
| 06/28/2007 | US20070148208 Anti-excititoxic sustained release intracular implants and related methods |
| 06/28/2007 | US20070148207 Therapeutic inhibitor of vascular smooth muscle cells |
| 06/28/2007 | US20070148205 Prevention of Arterial Restenosis with Active Vitamin D Compounds |
| 06/28/2007 | US20070148197 Treating inflammation with ondansetron and pharmaceutical compositions comprised thereof |
| 06/28/2007 | US20070148195 Compositions and methods for transdermal oxybutynin therapy |
| 06/28/2007 | US20070148193 Lutein concentrate |
| 06/28/2007 | US20070148192 Stable ophthalmic composition |
| 06/28/2007 | US20070148191 Use of ligands of specific antigen for the diagnosis and treatment of solid tumours and bone-related cancerous diseases |
| 06/28/2007 | US20070148185 Novel therapeutic target for protozoal diseases |
| 06/28/2007 | US20070148181 Ganglioside based vaccine compositions for subcutaneous administration |
| 06/28/2007 | US20070148178 Using beacizumab and antitumor agent as therapeutic treatment for mesothelioma |
| 06/28/2007 | US20070148177 Treatment with anti-vegf antibodies |
| 06/28/2007 | US20070148173 Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of Alpha V Beta 6 |
| 06/28/2007 | US20070148172 Method for the treatment of inflammatory bowel disease |
| 06/28/2007 | US20070148159 Use of crotoxin as an analgesic - CIP |
| 06/28/2007 | US20070148154 Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs |
| 06/28/2007 | US20070148144 Gene-enhanced tissue engineering |
| 06/28/2007 | US20070148135 Combination bacteriolytic therapy for the treatment of tumors |
| 06/28/2007 | US20070148132 Nervous system disorder; includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system; tightly regulatable gene delivery vector |
| 06/28/2007 | US20070148128 Carbodiimide crosslinking of functionalized polyethylene glycols |
| 06/28/2007 | US20070148127 Antimicrobial ophthalmic treatment system and method |
| 06/28/2007 | US20070148125 Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 06/28/2007 | US20070148124 Cellulose and acrylic based polymers and the use thereof for the treatment of infectious diseases |
| 06/28/2007 | US20070148123 Substances and agents for positively influencing collagen |
| 06/28/2007 | US20070148110 Aqueous-alcoholic depigmenting gels comprising mequinol and adapalene |
| 06/28/2007 | US20070148108 Stable vitamin b6 derivative |
| 06/28/2007 | US20070148099 Use of aroma compounds as defoaming agents for ophthalmic solutions with high concentrations of surfactants |
| 06/28/2007 | US20070148093 Non-terminal method of identifying anti-migraine compounds |
| 06/28/2007 | DE202007005123U1 Kosmetische, pharmazeutische und/oder dermatologische Zusammensetzungen enthaltend langkettige Fettalkohole und/oder deren Derivate Cosmetic, pharmaceutical and / or dermatological compositions comprising long chain fatty alcohols and / or derivatives thereof |
| 06/28/2007 | DE20122735U1 Verwendung einer Zubereitung für Restenoseprophylaxe Use of a composition for prophylaxis of restenosis |
| 06/28/2007 | DE102006059063A1 Verwendung von BAY 59-3074 zur Herstellung von Medikamenten zur Therapie von Hirntumoren sowie Kombinationen von BAY 59-3074 The use of BAY 59-3074 for the preparation of medicaments for the therapy of brain tumors, as well as combinations of BAY 59-3074 |
| 06/28/2007 | DE102006057027A1 Benzochromenderivate Benzochromene derivatives |
| 06/28/2007 | DE102005062742A1 Sulfoximin substituierte Pyrimidine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel Sulfoximine substituted pyrimidines, process for their preparation and their use as medicaments |
| 06/28/2007 | DE102005062741A1 Fluorene und Carbazole als Liganden des EP2 Rezeptors Fluorene and carbazole as ligands of the EP2 receptor |
| 06/28/2007 | DE102005062145A1 Ingwerextrakt zur Inhibierung humaner Arzneistofftransporter Ginger extract to inhibit human drug transporters |
| 06/28/2007 | DE102005062098A1 Oxaphenanthren-Derivate Oxaphenanthren derivatives |
| 06/28/2007 | DE102005061840A1 Triazolderivate Triazole derivatives |